ConductScience.org, home

Paper374177

Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial.

Uribe M and 4 others. Gastroenterology, 1979. Cited by 71 papers, by iCite.

Cite this record

ConductScience Library. Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial. Papers, record 374177. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/374177

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial.
PubMed
Journal
Gastroenterology
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
3.41
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Uribe MM
2Farca AA
3Márquez MAM A
4Garcĭa-Ramos GG
5Guevara LL

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BromocriptineMajor topic
Hepatic EncephalopathyMajor topic
Ammonia
Chronic Disease
Clinical Trials as Topic
Double-Blind Method
Electroencephalography
Female
Humans
Liver Cirrhosis
Male
Mental Processes
Recurrence

Source PubMed

Download CSV of topics

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
35646276Evidence-based approach to management of hepatic encephalopathy in adults.World J Hepatol2022https://conductscience.org/library/papers/35646276PubMed
24515383Dopamine agents for hepatic encephalopathy.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24515383PubMed
23086199Parkinsonism in cirrhosis: pathogenesis and current therapeutic options.Metab Brain Dis2013https://conductscience.org/library/papers/23086199PubMed
21994873Management of hepatic encephalopathy.Int J Hepatol2011https://conductscience.org/library/papers/21994873PubMed
21278704Hepatic encephalopathy: an updated approach from pathogenesis to treatment.Med Sci Monit2011https://conductscience.org/library/papers/21278704PubMed
20518580Pharmacotherapy for hepatic encephalopathy.Drugs2010https://conductscience.org/library/papers/20518580PubMed
19707277Current trends in the treatment of hepatic encephalopathy.Ther Clin Risk Manag2009https://conductscience.org/library/papers/19707277PubMed
12602516Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy.Metab Brain Dis2002https://conductscience.org/library/papers/12602516PubMed
11726085Movement dysfunction and hepatic encephalopathy.Metab Brain Dis2001https://conductscience.org/library/papers/11726085PubMed
11152016Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management.Drugs2000https://conductscience.org/library/papers/11152016PubMed
7427087Endocrine aspects of liver disease.Br Med J1980https://conductscience.org/library/papers/7427087PubMed
7238264Hyperprolactinemia in portal systemic encephalopathy.Dig Dis Sci1981https://conductscience.org/library/papers/7238264PubMed
7062015Hypothalamic-pituitary dopaminergic function in hepatic failure in man.J Neural Transm1982https://conductscience.org/library/papers/7062015PubMed
7016484Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study.Dig Dis Sci1981https://conductscience.org/library/papers/7016484PubMed
7004808Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients.Dig Dis Sci1980https://conductscience.org/library/papers/7004808PubMed
6818270Lack of dissociation of prolactin responses to thyrotropin releasing hormone and metoclopramide in chronic alcoholic men.J Endocrinol Invest1982https://conductscience.org/library/papers/6818270PubMed
6779933Management of hepatic encephalopathy.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6779933PubMed
6756833Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study.Dig Dis Sci1982https://conductscience.org/library/papers/6756833PubMed
6390989Portacaval shunts.World J Surg1984https://conductscience.org/library/papers/6390989PubMed
6360816Progress in the treatment of chronic portasystemic encephalopathy.Gut1984https://conductscience.org/library/papers/6360816PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/374177

GET https://conductscience.org/api/papers/v1/374177/cited_by?page=2